- Filed
- May 5, 2017 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2017 · May 1, 2017 | 108.3M sh |
| Capex | Q1 2017 · Mar 31, 2017 | $27K |
| Capex restated | Q1 2017 · Mar 31, 2016 | $311K |
| Operating Cash Flow | Q1 2017 · Mar 31, 2017 | −$13.35M |
| Operating Cash Flow | Q1 2017 · Mar 31, 2016 | −$19.09M |
| Short Term Debt | Q1 2017 · Mar 31, 2017 | $167.88M |
| Cash And Equivalents | Q1 2017 · Mar 31, 2017 | $44.81M |
| Cash And Equivalents | Q1 2017 · Dec 31, 2016 | $63.51M |
| Cash And Equivalents | Q1 2017 · Mar 31, 2016 | $63.82M |
| Cash And Equivalents | Q1 2017 · Dec 31, 2015 | $46.97M |
| Stockholders Equity | Q1 2017 · Mar 31, 2017 | −$77.21M |
| Stockholders Equity | Q1 2017 · Dec 31, 2016 | −$82.25M |
| Current Liabilities | Q1 2017 · Mar 31, 2017 | $184.08M |
| Current Liabilities | Q1 2017 · Dec 31, 2016 | $16.29M |
| Total Liabilities | Q1 2017 · Mar 31, 2017 | $184.08M |
| Total Liabilities | Q1 2017 · Dec 31, 2016 | $192.3M |
| Current Assets | Q1 2017 · Mar 31, 2017 | $49.81M |
| Current Assets | Q1 2017 · Dec 31, 2016 | $68M |
| Total Assets | Q1 2017 · Mar 31, 2017 | $118.38M |
| Total Assets | Q1 2017 · Dec 31, 2016 | $135.71M |
| Sga Expense | Q1 2017 · Mar 31, 2017 | $9.19M |
| Sga Expense restated | Q1 2017 · Mar 31, 2016 | $11.64M |
| Rd Expense | Q1 2017 · Mar 31, 2017 | $6.97M |
| Rd Expense | Q1 2017 · Mar 31, 2016 | $8.23M |
| Net Income | Q1 2017 · Mar 31, 2017 | −$22.59M |
| Net Income | Q1 2017 · Mar 31, 2016 | −$26.51M |
| Operating Income | Q1 2017 · Mar 31, 2017 | −$11.14M |
| Operating Income restated | Q1 2017 · Mar 31, 2016 | −$17.48M |
| Cost Of Revenue | Q1 2017 · Mar 31, 2017 | $1.25M |
| Cost Of Revenue restated | Q1 2017 · Mar 31, 2016 | $1.3M |
| Revenue | Q1 2017 · Mar 31, 2017 | $4.52M |
| Revenue restated | Q1 2017 · Mar 31, 2016 | $4.89M |